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Abstract
Individual studies have assessed the association between TNF-α-308G>A and TNF-α-238
G>A polymorphisms and severity of dengue infection. However, the results are inconclusive
and most studies had small sample sizes. The objective of this study was to summarize the
evidence of association between TNF-α-308 G>A and TNF-α-238 G>A and severity of den-
gue infection.
This study follows the preferred reporting items for systematic reviews and meta- analy-
ses of genetic association studies, recommended by PLOS One. We calculated pooled
odds ratio and its 95% confidence interval (CI) to estimate the association between TNF-α-
308 G>A or TNF-α-238 G>A and the risk of severe dengue infections. To determine the
information size required for this meta-analysis study, a trial sequential analysis (TSA) was
done. Eight studies (640 cases and 1275 controls), which assessed the association of TNF-
α-308 G>A or TNF-α-238 G>A and the risk of DHF were included. Overall, we found no sig-
nificant association between TNF-α-308 G>A and the DHF risk in the allelic model (OR,
0.91; 95% CI, 0.51–1.63), the recessive model (OR,1.32;95%CI,0.73–2.37), the dominant
model (OR,0.93;95%CI:0.59–1.47) or the additive model (OR,1.43,95;95%CI:0.79–2.59).
There was also no significant association between TNF-α-238 G>A and DHF risk under the
allele contrast model (OR:1.51;95%CI:0.88–2.58), the recessive model (OR,1.48,95%
CI:0.33–6.58), the dominant model (OR,1.48;95%CI:0.56–3.92), or the additive model
(OR:1.5;95%CI:0.34–6.69). On subgroup analysis, neither the Asian population nor the
non-Asian population showed significant association between TNF-α-308 G>A/TNF-α-238
G>A and the DHF risk under any genetic models. Leave-one-out meta-analysis showed sta-
bility of the results. TSA plots suggested that the sample size in this meta-analysis study
was below the required information size.
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The findings suggest an inclusive evidence of the association between TNF-α-308/ TNF-
α-238 G>A and the risk of developing severe dengue infection. Large studies with evidence
of Hardy-Weinberg equilibrium, assessing gene-gene interactions are recommended.
Introduction
Dengue fever is endemic in the tropics and sub-tropics and it is the most common arboviral
infection caused by dengue viruses (DENV-1, -2, -3, and -4), which are transmitted primarily
by the bite of Aedes aegypti and Ae. albopictus mosquitoesThe clinical manifestations of DENV
infection vary from mild (asymptomatic, undifferentiated fever, dengue fever) to the severe
form of dengue haemorrhagic fever (DHF). It is estimated that 2.5 billion people worldwide
are at risk for DENV infection. About 5% of those at risk will have severe forms such as DHF
and dengue shock syndrome (DSS), which are potentially fatal [1,2].
The exact pathogenesis of progression from mild to severe forms of dengue infections is
not known. A number of studies have suggested that leakage of plasma, which differentiates
DHF from DF is attributed to the direct and indirect effects of cytokines or chemical mediators
on the vascular endothelial cells [3–5]. In animal models, TNF-α has been implicated in the
process of plasma leakage and shock [6].
There is an array of polymorphisms regulating the TNF-α gene, of which the two most fre-
quently investigated are at position -308 [7] and at -238 in the promoter region [8]. Meta-anal-
yses have documented the association between TNF-α and the increased risk of colorectal
cancer under the homozygote model [9], and for pulmonary tuberculosis [10].
Individual studies assessing the association between the TNF-α-308 G>A or TNF-α-238
G>A promoter polymorphism and the risk of dengue infections in different populations are
available in the literature. However, the results are inconsistent. Most of these studies are
based on small sample sizes, with low statistical power. A meta-analysis of available individual
genetic association studies is valuable to ascertain whether the polymorphisms of TNF-α-308
G>A and TNF-α-238 G>A gene affect the risk of severe dengue infections. Published meta-
analyses in this field are also available, but there are concerns related to the selection of studies
included [11], the SNPs included [12], the accuracy of data extracted [12] and genetic models
undertaken [11]. Taken together, the objective of this review was to summarize the evidence of
association between TNF-α-308 G>A or TNF-α-238 G>A and severity of dengue infection.
Materials and methods
The current study conformed to the checklist for meta-analysis of genetic association studies
specified for PLOS One approach [13] (S1 Table).
Study search
The potentially relevant studies were searched in the health-related databases of PubMed,
Ovid Medline, google scholar and web of science and with the combination of the keywords
with Boolean operators: “dengue” OR “DHF” OR “dengue haemorrhagic fever” OR “DSS” OR
“dengue shock syndrome” AND “tumour necrosis factor- alpha-308” OR “rs1800629” OR
“TNF-α-308 G>A” OR “tumour necrosis factor-alpha” OR “TNF-α-238 G>A”. The details of
search in PubMed database is provided in S2 Table.
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The search was restricted to the publications in English until January 2018. We also
searched manually the references of articles retrieved and relevant systematic reviews to find
any additional studies.
Inclusion criteria
Human studies of any sample size that assessed severe dengue infection were included, if (1)
TNF-α-308 G>A (including rs 1800629), TNF-α-238 G/A or both were investigated; (2) they
were case-control design (retrospective or nested case-control) with an outcome of severe den-
gue infections (DHF/DSS) measured as incidence or prevalence, and (3) there was sufficient
information to extract the genotype frequency both in cases and controls.
Severe dengue infection in the current analysis encompassed DHF and/or DSS as defined
in the primary studies. Studies, which did not meet the inclusion criteria were excluded. Stud-
ies based on family or sibling-pairs were not considered.
Data extraction
Two investigators independently screened the titles and abstracts, and then selected the rele-
vant full-text articles, according to the inclusion criteria. The two investigators independently
extracted data, using a piloted data extraction form. Information collected from each study
included: first author, publication year, country, study setting (e.g. hospital-based or popula-
tion-based), the frequency of cases and controls, the racial descent (Asian or non-Asian),
method of genotyping and genotype/allele frequencies in cases and controls. If allele frequency
was zero, then we added 1 to all allele, following the Laplace approximation [14]. Any discrep-
ancy between the two investigators were resolved by consensus.
Assessment of the methodology quality
The two investigators independently evaluated the methodological quality of studies with the
use of the Newcastle-Ottawa Scale (NOS) [15]. These scores are based on three factors such as
the selection of the study groups (4 points), the comparability of the groups (2 points) and the
ascertainment of the exposure (3 points). The total score for each study ranged between 0 (the
worst) and 9 (the best). As described in a published systematic review [16], we adapted the cut-
off score points as good (7), moderate (5) and poor (4) for study quality assessment. Any
discrepancy between the two investigators was resolved by consensus.
Statistical analysis
An evidence of HWE in the control population was assessed (if not provided in the study
included) or re-assessed (if already provided) in this meta-analysis with the use of the good-
ness-of-fit test (p>0.05) [17].
Following a method described [18], the strength of the association between TNF-α-308
G>A or TNF-α-238 G>A and the risk of developing DHF/DSS was estimated using odds
ratios (ORs) and its 95% confidence intervals (CIs) for individual studies included. Heteroge-
neity was evaluated with the use of I2 test. The I2 test values indicates the percentage of total
variation across studies that is attributable to the heterogeneity rather than chance. I2 values lie
between 0% and 100%, with greater than 50% regarded as having substantial heterogeneity
[19]. For pooling of the estimates across studies included, the summary ORs and its 95% CIs
were calculated with random-effect model (The Der Simonian and Laird method), based on
the presence of statistical heterogeneity of the studies. Otherwise, fix-effect model (the Mental-
Haenszel method) was used. We calculated the summary ORs and its 95% CIs in four genetic
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models: the allelic contrast model (A vs G), the dominant model (AA+GA vs GG), the reces-
sive model (AA vs GA+GG), and the additive model (AA vs GG). To investigate the stability of
results, a sensitivity analysis was done with leave-one-out meta-analysis by omitting one study
at a time [20]. All eight studies included used different case definitions of dengue severity.
Hence, a sensitivity analysis was done with the studies that used the WHO 1997 definition for
dengue severity. We did not assess the publication bias by visual inspection of funnel plots in
the absence of a minimum 10 studies required for this assessment [21,22].
Trial sequential analysis (TSA), a tool for adjustment of random error risk, was done for
estimation of the required information size [23]. It is classified as ‘firm evidence of effect’ or
‘potentially spurious evidence of effect’; this classification depends on the cumulative Z-curve
that cross the monitoring boundaries or not [24].
Forest plots and leave-one-out meta-analysis were done with RevMan 5.3 (The Cochrane
collaboration, Copenhagen) and meta package in R 3.4.3 software (The R Foundation), respec-
tively. TSA plot was done with TSA software (Copenhagen Trial Unit, Centre for Clinical
Intervention Research, Copenhagen).
Results
Study search results
Fig 1 shows a four-phase study selection process in this meta-analysis. A total of 167 records
were found in the initial search, of which 32 were duplicates. After screening of abstracts, 19
full-text articles were retrieved, based on the inclusion criteria. Finally, eight studies (with 640
cases and 1275 controls) were identified for this review [25–32]. All these eight studies assessed
TNF-α-308 G>A. Only 3 studies assessed both TNF-α-308 G>A and TNF-α 238 G>A
[26,30,32] in the risk of severe dengue. Summary of the 11 excluded studies [33–43] were pro-
vided in S3 Table.
Study characteristics
Table 1 presents the characteristics of the nine included studies, along with their genotype and
allele frequency distribution of TNF-α-308 G>A and TNF-α-238 G>A gene polymorphisms.
Two studies each were from Brazil [27, 31] and Mexico [26,32], while one study each from
Cuba [25], India [28], Malaysia [30] and Sri Lanka [29]. Study samples varied from 43 cases
[25] to 196 [30]. The years of publication spanned from 2010 and 2017. The single nucleotide
polymorphisms (SNPs) in two studies deviated from HWE [25, 26]. All these eight studies
were with moderate to good methodological quality, based on the NOS criteria (S4 Table).
Quantitative estimates
Overall, there were no significant associations between TNF-α-308 G>A and the DHF risk
under the allelic model (OR,0.91;95% CI,0.51–1.63,I2:81%), the recessive model (OR,1.32, 95%
CI; 0.73–2.37,I2:0%), the dominant model (OR,0.93;95%CI:0.59–1.47,I2:64%) and the additive
model (OR,1.43;95%CI:0.79–2.59, I2:0%). On stratification, the Asian population or the non-
Asian population showed no significant relationships between TNF-α-308 G>A and the DHF
risk under any genetic models, except a recessive model with the Asian population (0.47, 95%
CI: 0.23–0.85, I2: 67%) (Fig 2A, 2B, 2C and 2D).
For TNF-α-238 G>A, overall there was no significant association with the DHF risk in the
allelic model (OR,1.51;95%CI,0.88–2.58,I2:68%), the recessive model (OR,1.48,95%CI,0.33–
6.58,I2:0%), the dominant model (OR,1.48;95%CI:0.56–3.92,I2:60%) and the additive model
(OR,1.5;95%CI:0.34–6.69,I2:0%). Also, a stratified analysis with the Asian population or the
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non-Asian population did not show significant association between TNF-α-238 G>A poly-
morphism and the risk of DHF in any genetic models (Fig 3A, 3B, 3C and 3D).
To evaluate the impact of individual data on the pooled ORs, sensitivity analysis was per-
formed using leave-one-out meta-analysis. For instance, the overall estimate of dominant
model of TNF-α-238 G>A remained as having no statistical significance, on omitting any sin-
gle study (Fig 4), indicating that the results are stable. Another sensitivity analysis was done
with the studies that used the WHO 1997 definition for dengue sensitivity. We also found no
significant association between TNF-α-308 G>A polymorphism and the risk of DHF in allelic
genetic models (OR: 1.08, 95%CI: 0.49–2.37, I2: 83%) (S5 Table). This was also true for the
other genetic models.
Trial sequential monitoring
We performed TSA with six studies that followed evidence of HWE [27–32]. We plotted with
the use of an overall type I error of 5% and type II error of 20%. The currently included total
participants in this meta-analysis was below the required information size of 4059. As the
cumulative Z-curve (blue full line with quadratic indications of each trial) touches the
Fig 1. PRISMA flow diagram showing the study selection process.
https://doi.org/10.1371/journal.pone.0205413.g001
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boundary for futility, it will be unlikely to reach a statistical significance p<0.05, even the
required information size of 4059 is obtained (Fig 5). This was also true for TNF- α -238 G>A.
Discussion and conclusions
The current study provides evidence on the relationship between TNF-α-308 G>A or TNF-α-
238 G>A and the risk of DHF, and the major observations are as follows;
Table 1. Characteristics of the studies included in the meta-analysis.
Study Yr Ref
#
Country Setting Diagnostic
criteria
Genotyping DHF cases/
Healthy
controls
Age group Study
quality score
Cases Controls
A/G AA/
GA/GG
A/G AA/GA/
GG
Perez 2010 25 Cuba population
based
1997 WHO
criteria
PCR-SSP 43/99 adults 7 29/57 9/11/
23
21/145 14/7/69
Garcı´a-
Trejo
2011 26 Mexico hospital
based;
1997 WHO
criteria
PCR-RFLP 45/169 adults 7 0/64 0/0/32 23/315 1/21/147
Xavier-
Carvalho
2013 27 Brazil hospital
based;
2009 WHO/
TDR
Real-time
PCR
88/335 children 8 20/144 2/16/
64
73/585 6/66/271
Alagarasu 2015 28 India hospital
based
1999 WHO
criteria
ARMS-PCR 45/108 adults 8 6/84 0/6/39 13/203 0/13/95
Fernando 2015 29 Sri
Lanka
hospital
based
2011 WHO
criteria
ARMS-PCR 107/52 adults 5 14/200 2/10/
95
28/107 2/13/47
Sam 2015 30 Malaysia hospital
based
1997 WHO
criteria
PCR-RFLP 196/120 Mostly
adults
8 17/373 0/17/
178
24/216 1/22/97
dos Santos 2017 31 Brazil hospital
based
1997 WHO
criteria
Real-time
PCR
49/135 adults 7 10/88 0/10/
39
39/231 3/33/99
Sanchez-
Leyva
2017 32 Mexico hospital
based
1997 WHO
criteria
PCR-RFLP 67/257 adults 9 12/122 3/6/58 35/497 2/31/224
https://doi.org/10.1371/journal.pone.0205413.t001
Fig 2. Forest plot of the associated TNF-α-308 G>A and dengue haemorrhagic fever (A: Allele contrast model, B:
Recessive model, C: Dominant model, D: Additive model).
https://doi.org/10.1371/journal.pone.0205413.g002
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1. In a combined population as well as subgroups of Asian and non-Asian groups, both SNPs
(TNF-α-308 G>A and TNF-α-238 G>A were not significantly associated with the DHF
risk in almost all genetic models investigated.
2. The TSA plot revealed that the required information size for evidence of effect was insuffi-
cient to draw a firm conclusion.
The plasma leakage in DHF occurs up to several days after viremia has been reduced or dis-
appeared, suggesting the role of an immune-mediated mechanism in DHF [6, 7]. TNF-α gene
was first cloned in 1985 and it is expressed in diverse cells including macrophages and tumour
cells. Although an exact mechanism is not fully understood, the action of TNF-α includes stim-
ulating the acute phase response that lead to increase in the C-reactive protein levels, and
Fig 3. Forest plot of the associated TNF-α-238 G>A with dengue haemorrhagic fever (A: Allele contrast model; B:
Recessive model, C: Dominant model, D: Additive model).
https://doi.org/10.1371/journal.pone.0205413.g003
Fig 4. Leave-one-out meta-analysis for the TNF-α-308 G>A under the dominant model.
https://doi.org/10.1371/journal.pone.0205413.g004
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producing IL-1 oxidant and inflammatory lipid prostaglandin E-2 [7]. An in vitro study has
reported that acute dengue sera had significantly high TNF-α levels, and the endothelial activa-
tion was inhibited more than 70% with pre-treatment of monoclonal antibodies against TNF-
α. This could explain why the transient plasma leakage occurred mainly at serosal tissues in
dengue cases [4,44].
A published meta-analysis has documented that TNF- α -308 G>G genotype and allele G
confer susceptibility to symptomatic dengue, while TNF- α -308 G>A genotype and allele A
confer protection [12]. The current analysis, which focussed on the severe form of infection
with potential fatality such as DHF/DSS, showed no significant relationship between TNF-α-
308 G>A and the DHF risk. This difference is related to variation in immunopathology of the
target conditions as the clinical outcome of symptomatic dengue and severe dengue, are not at
the same degree of importance. The findings in this analysis were comparable with another
meta-analysis of seven individual studies (n = 1533), suggesting that TNF-α-308 G>A was not
associated with DHF [12]. Although there are more participants in this analysis the results
retained the evidence of no association. Moreover, the current review assessed more than one
SNP.
The lack of association either protective or enhancement of the DHF risk in the current
analysis might be due to insufficient number of participants, which is supported by the TSA
plot. It showed that the included eight studies in this meta-analysis could only contribute to
65.7% of the required information size. This implied there was insufficient information to pro-
vide conclusive results.
Another possible reason of a lack of association in the present analysis may be due to the
limited role of TNF-α in the development of DHF risk. In animal models, IFN-γ does not
directly induce plasma leakage, but promotes TNF-α production through activated monocytes
[45] and interactions with TNF-α to activate endothelial cells [46]. As such, it is likely that the
combined cytokines including TNF-α-308 G>A and other cytokines are important to establish
the significant role in the DHF risk. This was supported by a study in Malaysia that showed a
significant correlation between interactions of TNF-α-308G>A genotype and IL10 non-GCC
haplotypes, IL12B pro homozygotes (pro1/pro1, pro2/pro2) and IL-12B 3’UTR AC and the
Fig 5. Trial sequential monitoring plot of TNF-α-308 G>A in severe dengue infection.
https://doi.org/10.1371/journal.pone.0205413.g005
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protective effects against DHF/DSS [30]. It has been suggested that the interactions of TNF-α,
IFN- γ and activated complement proteins enhance plasma leakage of endothelial cells in sec-
ondary dengue infection [42]. A small number of studies did not allow to perform pooled anal-
ysis with these combined cytokines. The studies identified for the current meta-analysis used
different case definition of dengue severity. Some used 2009 WHO definition, some used 1997
definition. Both definitions of the WHO 1997 and 2009 may include the patients with different
disease severity, which may not relate to vascular permeability. However, a sensitivity analysis
solely on the five studies that used WHO 1997 definition remained the non-significant associa-
tion between TNF-α-308 G>A and the risk of severe dengue. This implied that the criteria for
dengue severity had no impact on the direction of association.
Study limitations
We acknowledge the limitations of the present review. Approximately 75% of the global popu-
lation residing in the Asia Pacific Region are exposed to DENV [47]. Only 36% of the included
studies were carried out in the Asia Pacific Region; there is a likely selection bias with geo-
graphical imbalance. The current analysis was done with the unadjusted raw data provided in
the primary studies, whereas most of the estimations in the individual studies might have been
adjusted with common factors (i.e. age, gender). Hence, the pooled ORs in this meta-analysis
may be slightly differed from what was reported in the primary adjusted studies. If cases and
controls have been genotyped in separate batches in the primary studies, a bias related to dif-
ferential misclassification of exposure is a concern. Due to the small sample sizes in most of
the included studies, type II errors had limited to find the significant differences between the
cases and controls or amongst the ethnic groups. However, meta-analysis is a retrospective
pooling of published studies, and type II errors are less likely than in individual studies [48].
We planned to do stratified analysis by age group. This was not possible in view of only one
study with children. Moreover, there might be some extent of interaction with TNF-α-238
G>A or TNF-α-308 G>A and other genes (gen-gen interaction/synergism) or other potential
confounding factors such as nutritional status of the patients included [16]. Hence, findings in
this meta-analysis should be interpreted with cautions.
There are some strengths in this meta-analysis compared with other reviews in this field.
To be comprehensive, we have added more than one SNP in the present analysis. We per-
formed this review, following the guideline for meta-analysis of genetic association studies
[13]. Moreover, the TSA technique was useful to adjust random-error risk. An add-on TSA
approach to this field will highlight to researchers about the optimal sample size to adopt. This
will help the researchers and policy makers to reach a more balanced conclusion on the esti-
mates [24], which is the case in this study. In summary, the findings suggest that it is inconclu-
sive to determine whether any of these two SNPs is associated with the risk of severe dengue
infection. Additional case-control studies on these two SNP may likely to change the estimates.
Large studies with evidence of HWE, assessing these SNPs and other SNPs as gene-gene inter-
actions are recommended.
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